Revenio Group Oyj · OMXHEX:REG1V
Revenio Group Oyj — Q1 2024 Earnings Presentation
16 slides from Revenio Group Oyj's earnings presentation, Apr 25, 2024
Slide 1: Q1/2024 Interim Report
Q1/2024 INTERIM REPORT Soft start for the year as expected, however, net cash flow from operations was strong CEO Jouni Toijala & CFO Robin Pulkkinen
Slide 2: Disclaimer
Disclaimer This presentation does not constitute an invitation to underwrite, subscribe for, or otherwise acquire or dispose of any Revenio's shares. Revenio’s past performance is no guide to future performance, and persons needing advice should consult an independent financial adviser. This present
Slide 3: Presenting today
Presenting today Jouni Toijala Robin Pulkkinen CEO CFO Q 1 / 2 0 2 4
Slide 4: Agenda
Agenda Highlights of Q1/2024 Financials Shareholders and financial guidance Q 1 / 2 0 2 4
Slide 5: January – March 2024 highlights
January – March 2024 highlights • Net sales totaled EUR 23.6 (23.2) million, an increase of 1.8% • The currency-adjusted net sales in January–March decreased 0.5% • Operating profit was EUR 5.1 (6.2) million, or 21.8% of net sales, Net sales EBIT down by 16.6% 23.6 5.1 • EBITDA was EUR 6.2 (7.1) mil
Slide 6: Business highlights of Q1/2024
Business highlights of Q1/2024 The sales increased particularly in the United We decided to apply for the U.S. Food and States and EMEA. Sales of the iCare IC200 Drug Administration (FDA) approval for iCare tonometer developed positively in the first ILLUME screening solution. The FDA quarter and th
Slide 7: Financials
Financials Robin Pulkkinen CFO
Slide 8: Development of Revenio's key figures
Development of Revenio’s key figures MEUR 1-3/2024 1-3/2023 Change-% Net sales 23.6 23.2 1.8 Gross margin 16.6 16.4 1.6 - Exchange rates improved the net sales in the review period. Gross margin, % 70.3 70.5 -0.2 Exchange rate-adjusted net EBITDA 6.2 7.1 -12.0 sales decreased by 0.5 percent EBITDA -
Slide 9: Soft start for the year as expected due to challenging comparables
Soft start for the year as expected due to challenging comparables Net sales (EUR million) 35 1,2 28,3 29,1 30 1 25 23,8 24,4 24,1 23,2 22,3 23,6 - Despite the challenging 18,9 19,4 20,2 22,0 0,8 comparables, our net sales 16,8 20 grew by 1.8% from last year. 0,6 15 - The sales increased 10 0,4 part
Slide 10: Profitability impacted by our decision to apply for FDA approval for iCare ILLUME
Profitability impacted by our decision to apply for FDA approval for iCare ILLUME screening solution Adjusted operating profit EUR million and % (EBIT) 10 33,1 9,5 35,0 32,6 31,7 31,3 30,7 27,5 32,6 9 29,2 8 7,7 7,7 9,3 26,6 28,1 30,0 - The FDA approval-related costs in 7 23,7 7,1 24,7 25,0 the revi
Slide 11: Net cash flow from operations was record high
Net cash flow from operations was record high Net cash flow from operating activities (EUR million) 14 12 11,0 11,7 - The net cash flow from operations was strong due to 10 smaller payments from the 8 7,1 incentive programs. 6 5,8 5,6 - In addition, paid taxes and trade 5,2 4,6 4,6 receivables decre
Slide 12: Strong balance sheet to secure financial flexibility
Strong balance sheet to secure financial flexibility Equity ratio and net gearing (%) 80 25,0 20,7 74,5 72,2 72,7 71,1 70 67,4 66,2 67,4 66,8 20,0 - The Annual General Meeting of 60,3 61,9 64,0 63,0 64,0 15,0 April 4, 2024, decided that a 60 10,0 dividend of EUR 0.38 per share be 11,2 7,0 paid. 50 6
Slide 13: Shareholders on March 31, 2024
Shareholders on March 31, 2024* No. of % Verified shares 1. William Demant Invest A/S 4,997,380 18.73% 2024-03-31 Finnish ownership Foreign ownership 2. SEB Funds 1,080,683 4.05% 2024-03-19 49.76% 50.24% 3. Vanguard 852,424 3.19% 2024-02-29 4. Swedbank Robur Funds 749,000 2.81% 2024-03-19 Owner dist
Slide 14: Financial guidance
Financial guidance Net sales Financial guidance for 2024 (published on February 15, 2024) 97,0 96,6 78,8 Revenio Group’s exchange rate- adjusted net sales are estimated to 61,1 grow 5-10 percent from the previous year and profitability, 49,5 excluding non-recurring items, is estimated to remain at a
Slide 15: Revenio
2024 REVENIO
Slide 16: We aspire to keep the wonderful world visible for all
“We aspire to keep the wonderful world visible for all”